AFP and diabetes mellitus: Taken together, the present study concluded that MT treatment regulates the blood glucose level, controls liver enzymes ALT and AST, and attenuates diabetes-induced hepatic injury by restoring pancreatic β-cells and their antioxidant effect, which decreases hepatocyte injury and downregulates AFP expression.